Difference between revisions of "Team:TP-CC San Diego/Results"
Claregao98 (Talk | contribs) |
Claregao98 (Talk | contribs) |
||
| Line 54: | Line 54: | ||
<img src="https://static.igem.org/mediawiki/2017/a/a1/T--TP-CC_San_Diego--EGFR.png" width="500"> | <img src="https://static.igem.org/mediawiki/2017/a/a1/T--TP-CC_San_Diego--EGFR.png" width="500"> | ||
<img src="https://static.igem.org/mediawiki/2017/f/f5/T--TP-CC_San_Diego--TLCV2.png width="500"> | <img src="https://static.igem.org/mediawiki/2017/f/f5/T--TP-CC_San_Diego--TLCV2.png width="500"> | ||
| + | |||
| + | <p> | ||
| + | We were able to confirm that the GBM39 cell line had a substantial copy number of the EGFR gene. From there, we designed 4 guide RNAs. Two from exon 1 and two from exon 8. We were unable to design any gRNA using exons 2-7 because in the GBM39 cell line, that portion of the EGFR gene is mutated. Using the TLCV2 backbone, we removed the stuffer sequence and inserted the guideRNAs in its place. We were successful with constructing 3 gRNAs but the 4th failed to clone twice. After Sequencing our plasmids, we transfected the guideRNAs into GBM39 cells. Currently, we are monitoring the growth of the cells. | ||
| + | </p> | ||
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
Revision as of 23:30, 29 October 2017
Results
DAY 1
SUMMARY of July 17th:
- DNA extraction from GBM39 cells
- Agarose gel electrophoresis to confirm DNA
DAY 2
SUMMARY of July 17th:
- DNA extraction from GBM39 cells
- Agarose gel electrophoresis to confirm DNA
We were able to confirm that the GBM39 cell line had a substantial copy number of the EGFR gene. From there, we designed 4 guide RNAs. Two from exon 1 and two from exon 8. We were unable to design any gRNA using exons 2-7 because in the GBM39 cell line, that portion of the EGFR gene is mutated. Using the TLCV2 backbone, we removed the stuffer sequence and inserted the guideRNAs in its place. We were successful with constructing 3 gRNAs but the 4th failed to clone twice. After Sequencing our plasmids, we transfected the guideRNAs into GBM39 cells. Currently, we are monitoring the growth of the cells.
